Literature DB >> 25494885

Improving target dose coverage and organ-at-risk sparing in intensity-modulated radiotherapy of advanced laryngeal cancer by a simple optimization technique.

J-Y Lu1, L-L Wu, J-Y Zhang, J Zheng, M L-M Cheung, C-C Ma, L-X Xie, B-T Huang.   

Abstract

OBJECTIVE: To evaluate a simple optimization technique intended to improve planning target volume (PTV) dose coverage and organ-at-risk (OAR) sparing in intensity-modulated radiotherapy (IMRT) of advanced laryngeal cancer.
METHODS: Generally acceptable initial IMRT plans were generated for 12 patients and were improved individually by the following two techniques: (1) base dose function-based (BDF) technique, in which the treatment plans were reoptimized based on the initial IMRT plans; (2) dose-controlling structure-based (DCS) technique, in which the initial IMRT plans were reoptimized by adding constraints for hot and cold spots. The initial, BDF and DCS IMRT plans and additionally generated volumetric modulated arc therapy (VMAT) plans were compared concerning homogeneity index (HI) and conformity index (CI) of PTVs prescribed at 70 Gy/60 Gy (PTV70/PTV60), OAR sparing, monitor units (MUs) per fraction and total planning time.
RESULTS: Compared with the initial IMRT and DCS IMRT plans, the BDF technique provided superior HI/CI, by approximately 19-37%/4-11%, and lower doses to most OARs, by approximately 1-7%, except for the comparable HI of PTV60 to DCS IMRT plans. Compared with VMAT plans, the BDF technique provided comparable HI, CI and most-OAR sparing, except for the superior HI of PTV70, by approximately 13%. The BDF technique produced more MUs and reduced the planning time.
CONCLUSION: The BDF optimization technique for IMRT of advanced laryngeal cancer can improve target dose homogeneity and conformity, spare most OARs and is efficient. ADVANCES IN KNOWLEDGE: A novel optimization technique for improving IMRT was assessed and found to be effective and efficient.

Entities:  

Mesh:

Year:  2014        PMID: 25494885      PMCID: PMC4614243          DOI: 10.1259/bjr.20140654

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  52 in total

1.  Is uniform target dose possible in IMRT plans in the head and neck?

Authors:  K A Vineberg; A Eisbruch; M M Coselmon; D L McShan; M L Kessler; B A Fraass
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-04-01       Impact factor: 7.038

2.  Volumetric modulated arc therapy for nasopharyngeal carcinoma: a dosimetric comparison with TomoTherapy and step-and-shoot IMRT.

Authors:  Szu-Huai Lu; Jason Chia-Hsien Cheng; Sung-Hsin Kuo; Jason Jeun-Shenn Lee; Liang-Hsin Chen; Jian-Kuen Wu; Yu-Hsuan Chen; Wan-Yu Chen; Shu-Yu Wen; Fok-Ching Chong; Chien-Jang Wu; Chun-Wei Wang
Journal:  Radiother Oncol       Date:  2012-01-09       Impact factor: 6.280

3.  Superficial parotid lobe-sparing delineation approach: a better method of dose optimization to protect the parotid gland in intensity-modulated radiotherapy for nasopharyngeal carcinoma.

Authors:  H B Zhang; X Lu; S M Huang; L Wang; C Zhao; W X Xia; S W Li; F L Wang; Y L Zhu; X Guo; Y Q Xiang
Journal:  Curr Oncol       Date:  2013-12       Impact factor: 3.677

4.  Optimal beam design on intensity-modulated radiation therapy with simultaneous integrated boost in nasopharyngeal cancer.

Authors:  Mei-Chun Cheng; Yu-Wen Hu; Ching-Sheng Liu; Jeun-Shenn Lee; Pin-I Huang; Sang-Hue Yen; Yuh-Lin Lee; Chun-Mei Hsieh; Cheng-Ying Shiau
Journal:  Med Dosim       Date:  2014-05-22       Impact factor: 1.482

5.  Improving IMRT dose accuracy via deliverable Monte Carlo optimization for the treatment of head and neck cancer patients.

Authors:  Nesrin Dogan; Jeffery V Siebers; Paul J Keall; Fritz Lerma; Yan Wu; Mirek Fatyga; Jeffrey F Williamson; Rupert K Schmidt-Ullrich
Journal:  Med Phys       Date:  2006-11       Impact factor: 4.071

6.  [Late neurotoxicity after nasopharyngeal carcinoma treatment].

Authors:  W Siala; W Mnejja; A Khabir; K Ben Mahfoudh; T Boudawara; A Ghorbel; M Frikha; J Daoud
Journal:  Cancer Radiother       Date:  2009-08-19       Impact factor: 1.018

Review 7.  Radiation-induced second cancers: the impact of 3D-CRT and IMRT.

Authors:  Eric J Hall; Cheng-Shie Wuu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-05-01       Impact factor: 7.038

8.  Intensity-modulated radiotherapy improves target coverage, spinal cord sparing and allows dose escalation in patients with locally advanced cancer of the larynx.

Authors:  Catharine H Clark; A Margaret Bidmead; Cephas D Mubata; Kevin J Harrington; Christopher M Nutting
Journal:  Radiother Oncol       Date:  2004-02       Impact factor: 6.280

9.  Clinical evaluation of direct aperture optimization when applied to head-and-neck IMRT.

Authors:  Stephen Jones; Matthew Williams
Journal:  Med Dosim       Date:  2008       Impact factor: 1.482

10.  Management of locally advanced laryngeal cancer.

Authors:  Alexander D Karatzanis; Georgios Psychogios; Frank Waldfahrer; Markus Kapsreiter; Johannes Zenk; George A Velegrakis; Heinrich Iro
Journal:  J Otolaryngol Head Neck Surg       Date:  2014-01-28
View more
  4 in total

Review 1.  Therapeutic Advancements in Metal and Metal Oxide Nanoparticle-Based Radiosensitization for Head and Neck Cancer Therapy.

Authors:  Poornima Dubey; Mathieu Sertorio; Vinita Takiar
Journal:  Cancers (Basel)       Date:  2022-01-20       Impact factor: 6.639

2.  Improving target coverage and organ-at-risk sparing in intensity-modulated radiotherapy for cervical oesophageal cancer using a simple optimisation method.

Authors:  Jia-Yang Lu; Michael Lok-Man Cheung; Bao-Tian Huang; Li-Li Wu; Wen-Jia Xie; Zhi-Jian Chen; De-Rui Li; Liang-Xi Xie
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240

3.  Flattening Filter-Free Beams in Intensity-Modulated Radiotherapy and Volumetric Modulated Arc Therapy for Sinonasal Cancer.

Authors:  Jia-Yang Lu; Jing Zheng; Wu-Zhe Zhang; Bao-Tian Huang
Journal:  PLoS One       Date:  2016-01-06       Impact factor: 3.240

4.  Analysis of dose distribution in organs at risk in patients with prostate cancer treated with the intensity-modulated radiation therapy and arc technique.

Authors:  Michał Biegała; Adam Hydzik
Journal:  J Med Phys       Date:  2016 Jul-Sep
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.